Zobrazeno 1 - 8
of 8
pro vyhledávání: '"329"'
Autor:
Alok A. Khorana, Fahrettin Covut, Yihong Zhou, Shafia Rahman, Shab E Gul Rahim, Sudha Amarnath
Publikováno v:
Blood. 132:1242-1242
Background:Venous thromboembolism (VTE) is a highly prevalent complication of cancer and its treatment and is commonly treated with anticoagulation1. However, there are limited data regarding the use of therapeutic anticoagulation in patients with br
Autor:
Yuan-Shung Huang, Brian T. Fisher, Richard Aplenc, Karen R. Rabin, Kelly D. Getz, Jennifer J. Wilkes, Viviane C. Cahen, Yimei Li, Lena E. Winestone, Amanda M. DiNofia, M. Monica Gramatges, Alix E. Seif, Caitlin W Elgarten
Publikováno v:
Blood. 132:624-624
Administrative databases can be used to study outcomes including patients outside of clinical trials and have been used to identify relapse and HSCT in adult and adolescent/young adult leukemia populations. However, there are no published studies usi
Autor:
Nicola Vianelli, Francesca Palandri, Margherita Perricone, Massimo Breccia, Nicola Polverelli, Roberto Latagliata, Emanuela Ottaviani, Michele Cavo, Giuseppe A. Palumbo, Lucia Catani, Giuliana Alimena, Francesco Merli, Giovanni Martinelli, Alessia Tieghi
Publikováno v:
Blood. 126:1614-1614
Introduction It is acknowledged that an accurate histological diagnosis may distinguish Essential Thrombocythemia (ET) from early Primary Myelofibrosis (early-PMF), which is projected to worse outcome in terms of survival and disease evolution into a
Publikováno v:
Blood. 126:4714-4714
Background Studies of hospital discharge data and large observational cohorts show that the incidence of venous thromboembolism (VTE) varies by race. We sought to determine the incidence of VTE in each of the following ethnic groups Caucasians, Afric
Autor:
Jennifer S. Temel, Tanya Keenan, Yi-Bin Chen, Harry VanDusen, Areej El-Jawahri, Daniel J. DeAngelo, Amir T. Fathi, Thomas W. LeBlanc, Philip C. Amrein, David P. Steensma, Lara Traeger, Richard Stone, Karen K. Ballen, Martha Wadleigh, Gregory A. Abel, Gabriela S. Hobbs
Publikováno v:
Blood. 126:2104-2104
Introduction: Older adults (≥ 60 years) with acute myeloid leukemia (AML) generally have a poor prognosis and a high rate of health care utilization including intensive care unit (ICU) admissions. While the outcomes of older patients with advanced
Autor:
Torsten Haferlach, Susanne Schnittger, Wolfgang Kern, Tamara Alpermann, Claudia Haferlach, Sabine Jeromin
Publikováno v:
Blood. 122:2776-2776
Background SF3B1 mutations (SF3B1mut) correlate with the presence of ring sideroblasts (RS) and can be found in MDS and in AML. Aim To evaluate the incidence of SF3B1mut in a large cohort of MDS and AML patients (pts) with ≥15% RS, and furthermore
Autor:
James L.M. Ferrara, Jochen Metzger, Arnold Ganser, Annika Krons, Hildegard T. Greinix, Ernst Holler, Gernot Beutel, Julia Kontsendorn, Michael Schleuning, Stefanie Buchholz, Anne M. Dickinson, N. Hahn, Hans-Jochem Kolb, Axel R. Zander, Eva Mischak-Weissinger
Publikováno v:
Blood. 114:347-347
Abstract 347 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for many hematologic malignancies or hematopoietic dysfunction syndromes, but the application is still limited due to major complications, such as sev
Autor:
Andrea Bacigalupo, Gérard Socié, Meral Beksac, Nigel H. Russell, Birte Friedrichs, Norbert Schmitz, Tapani Ruutu, Andre Tichelli
Publikováno v:
Blood. 112:451-451
In 2002, the EBMT reported on the largest prospective randomized study comparing filgrastim-mobilized peripheral blood progenitor cell (PBPC) to bone marrow (BM) transplantation (Schmitz et al. Blood 2002). Patient accrual took place between 02/95 an